Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN

BAYER AG (BAYN)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bayer Stops Sale of Glucose Meter Business

01/09/2013 | 06:07am US/Eastern

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at hendrik.varnholt@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Bayer AG, SANOFI
React to this article
Latest news on BAYER AG
08/03 BAYER : FDA Approves Bayer's Finacea (azelaic acid) Foam for the Topical Treatme..
07/29 SPRINT BIOSCIENCE : enters into collaboration with Bayer HealthCare on tumor met..
07/29 SPRINT BIOSCIENCE : Bayer HealthCare Enters Into Collaboration With Sprint Biosc..
07/29DJBayer Profit Rises on Healthy Currency Effects
07/29DJBayer Sees Benefits of Currency Effects With 21% Rise in 2Q Profit -- Update
07/29 BAYER : significantly improves earnings
07/29DJBayer Sees Benefits of Currency Effects With 21% Rise in 2Q Profit
07/28 GLENMARK PHARMACEUTICALS : slips 2% on negative US Court ruling
07/28 BAYER : Offering integrated solutions and driving partnerships to promote sustai..
07/28 BAYER : Not intended for U.S. and UK Media -- Bayer HealthCare Enters Into Colla..
Advertisement
Chart
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Income Statement Evolution
More Financials